Using FoundationOne Liquid, a novel liquid biopsy test providing targeted gene and microsatellite instability-high results, researchers sought to examine whether specific biomarkers contribute to TNBC ...
Yet ever since a close family member was diagnosed with Stage 4 renal cell carcinoma back in 2015, it has also been intensely personal. In dealing with docs, nurses, technology, I am routinely ...
IRVINE, Calif.--(BUSINESS WIRE)--Genomic Testing Cooperative, LCA (GTC) announced that it will be presenting at the American Society of Clinical Oncology (ASCO) 2022 annual meeting data showcasing its ...
News Medical on MSN
Novel liquid biopsy technology lowers barriers for more efficient cancer diagnostics
A novel liquid biopsy technology is set to advance cancer diagnostics and monitoring by overcoming the long-standing ...
A company developing liquid biopsy technology for the early detection of cancers has new data that it is presenting Saturday at a major cancer conference. Menlo Park, California-based Grail said it ...
Here we conclude our discussion with David P. Carbone, MD, PhD, The Ohio State University, by addressing the importance of both advocacy for and education on biomarker testing in the lung cancer space ...
Hosted on MSN
Liquid biopsy blood test shows superior sensitivity in detecting HPV-associated head and neck cancers
A new liquid biopsy blood test could help detect cases of human papillomavirus (HPV)-associated head and neck cancers with significantly higher accuracy than currently used methods, including before ...
Guardant Reveal™ is industry’s first blood-only test able to detect, with 7-day turnaround time, residual disease after surgery and recurrence months earlier than current standard-of-care methods ...
The UK National Health Service (NHS) England has rolled out a new liquid biopsy test intended to fast-track lung cancer patients to receive targeted therapy. Liquid biopsy testing works by detecting ...
PALO ALTO, Calif. & BARCELONA, Spain--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, and the Vall d’Hebron Institute of Oncology (VHIO), one of Europe’s ...
insights from industryErik GublerProduct ManagerMettler-Toledo GmbH In this interview, AZoM speaks to Erik Gubler, Product Manager at Mettler-Toledo GmbH, about e-liquid testing; how to do it, why it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback